EN
SR
Our Group
About us
We in Europe
Our Vision
Quality Assurance and Compliance
Contact
Our brands
PHOENIX
PHOENIX Pharma
Wholesale
Services in custom bonded warehouse
Logistic Support in Clinical trials
BETTY Pharmacies
LIVSANE Private label
EL Pharma
EL Pharma
Medical Affairs
Market Access
Regulatory
Marketing & Field force
Warehouse services
INO-Pharm
INO-Pharm
Specialty and Orphan medicines
Unlicensed medicines
Clinical Trials Logistic
BENU Pharmacies
Career
Perspective in PHOENIX
Why we
Press & News
News
Press releases and media contact
Dedicated to sustainability
Sustainability principles
Homepage
›
Press & News
Press releases
OBAVIJEST O POVLAČENJU I OPOZIVU ODREĐENIH SERIJA „BEBELAC 1“, 400 G, NUTRICIA
18.02.2026
Downloads
Bebelac.png (124 KB)
All press releases